EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Artemisinin and Its Derivatives as Potential Anticancer Agents

Luan Wen iD, Ben Chung-Lap Chan iD, Ming-Hua Qiu, Ping-Chung Leung iD, Chun-Kwok Wong iD

Molecules · 16.08.2024 · 29 (16) · 3886

DOI: 10.3390/molecules29163886 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 16.08.2024. Verfasst von Luan Wen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese Univer…. Hauptthemen laut MEDLINE: Artemisinins, Antineoplastic Agents. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Artemisinin is a natural sesquiterpene lactone obtained from the traditional Chinese medicinal herb Artemisia annua L. (qinghao). Artemisinin and its derivatives share an unusual endoperoxide bridge and are extensively used for malaria treatment worldwide. In addition to antimalarial activities, artemisinin and its derivatives have been reported to exhibit promising anticancer effects in recent decades. In this review, we focused on the research progress of artemisinin and its derivatives with potential anticancer activities. The pharmacological effects, potential mechanisms, and clinical trials in cancer therapy of artemisinin and its derivatives were discussed. This review may facilitate the future exploration of artemisinin and its derivatives as effective anticancer agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArtemisininsAntineoplastic AgentsHumansNeoplasmsArtemisia annuaAnimalsAntineoplastic Agents, PhytogenicAntimalarials

Stichwörter der Autor:innen

anticancer activityartemisininartesunatedihydroartemisinin

Substanzen

ArtemisininsAntineoplastic AgentsartemisininAntineoplastic Agents, PhytogenicAntimalarials

Autor:innen und Institutionen

  • Institute of Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Hong Kong, China.
  • State Key Laboratory of Phytochemistry and Plant Resources in West China, Yunnan Key Laboratory of Natural Medicinal Chemistry, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China.
  • Department of Chemical Pathology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
  • Li Dak Sum Yip Yio Chin R & D Centre for Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China.

ORCID-Profile: Luan Wen, Ben Chung-Lap Chan, Ping-Chung Leung, Chun-Kwok Wong

Förderung

  • State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants

Zitieren

APA

Wen, L., Chan, B. C., Qiu, M. H., Leung, P. C., & Wong, C. K. (2024). Artemisinin and Its Derivatives as Potential Anticancer Agents. Molecules, 29(16), 3886. https://doi.org/10.3390/molecules29163886

Vancouver

Wen L, Chan BC, Qiu MH, Leung PC, Wong CK. Artemisinin and Its Derivatives as Potential Anticancer Agents. Molecules. 2024;29(16):3886. doi:10.3390/molecules29163886

BibTeX
@article{Wen2024,
  author = {Wen, Luan and Chan, Ben Chung-Lap and Qiu, Ming-Hua and Leung, Ping-Chung and Wong, Chun-Kwok},
  title = {Artemisinin and Its Derivatives as Potential Anticancer Agents},
  journal = {Molecules},
  year = {2024},
  volume = {29},
  number = {16},
  pages = {3886},
  doi = {10.3390/molecules29163886}
}
Kostenlos starten →